FDA approves Progenics’ Azedra

Aug 03, 2018 , Drug Store News - Retail

Azedra is the first FDA-approved drug for treating adults and adolescents age 12 years old and older with rare adrenal tumors, according to Progenics Pharmaceuticals.

Read More

Read the full story...

Trending healthcare news keywords at this moment

study kids measles cancer blood risk opioid lives fda healthcare medicare care patients heart launches hospital shows drug sleep disease flu teen state tip data